Citigroup’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $996K | Sell |
22,928
-38,434
| -63% | -$1.67M | ﹤0.01% | 2528 |
|
|
2025
Q1 | $2.29M | Buy |
61,362
+5,260
| +9% | +$197K | ﹤0.01% | 1975 |
|
|
2024
Q4 | $2.54M | Buy |
56,102
+27,968
| +99% | +$1.27M | ﹤0.01% | 1959 |
|
|
2024
Q3 | $1.65M | Buy |
28,134
+10,023
| +55% | +$589K | ﹤0.01% | 2183 |
|
|
2024
Q2 | $713K | Sell |
18,111
-74,995
| -81% | -$2.95M | ﹤0.01% | 2476 |
|
|
2024
Q1 | $6.19M | Buy |
93,106
+89,337
| +2,370% | +$5.94M | ﹤0.01% | 1128 |
|
|
2023
Q4 | $105K | Buy |
+3,769
| New | +$105K | ﹤0.01% | 3444 |
|